Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy

29Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. The use of anti-malarial drug combinations with artemisinin or with one of its derivatives is now widely recommended to overcome drug resistance in falciparum as well as vivax malaria. The fixed oral dose artemisinin-naphthoquine combination (ANQ, ARCO) is a newer artemisinin-based combination (ACT) therapy undergoing clinical assessment. A study was undertaken to assess the safety, efficacy and tolerability of ANQ combination in areas of multi-drug resistance to generate preliminary baseline data in adult population of Papua New Guinea. Methods. The clinical assessment was an open-labeled, two-arm, randomized study comparing ANQ combination as a single dose regimen and three days regimen (10 mg/kg/day) of chloroquine plus single dose sulphadoxine-pyrimethamine (CQ+SP) for the treatment of uncomplicated falciparum malaria with 28 days follow-up in an adult population. The primary outcome measures for efficacy were day 1, 2, 3 7, 14 and 28-day cure rates. Secondary outcomes included parasite clearance time, fever clearance time, and gametocyte carriage. The main outcome measures for safety were incidences of post-treatment clinical and laboratory adverse events. Results. Between June 2005 and July 2006, 130 patients with confirmed uncomplicated P. falciparum were randomly assigned to receive ANQ and CQ+SP, only 100 patients (51 in ANQ group and 49 in CQ+SP group) were evaluated for clinical and parasitological outcomes. All the patients treated with ANQ and CQ+SP showed adequate clinical and parasitological response with 28 days follow-up. The cure rate for ANQ on day 1, 2, 3, 7, 14, and 28 was 47%, 86%, 92%, 94%, 94% and 94%, respectively. Recrudescence account for 6%; all were cleared on day 21. For CQ+SP treated group the cure rates were 24%, 67%, 82%, 82%, 84% and 88%, respectively. Recrudescence accounted for 10%; all were cleared on day 28 except for one patient. Both regimens were well tolerated with no serious adverse events. The proportion of gametocyte carriers was higher in CQ+SP treated group than ANQ treatment (41% versus 12%; p < 0.05). Conclusion. While these data are not themselves sufficient, it strongly suggests that the ANQ combination as a single dose administration is safe and effective for the treatment of uncomplicated P. falciparum malaria in the adult population of Papua New Guinea and deserves further clinical evaluation. © 2009 Hombhanje et al; licensee BioMed Central Ltd.

References Powered by Scopus

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

518Citations
N/AReaders
Get full text

Preventing antimalarial drug resistance through combinations

219Citations
N/AReaders
Get full text

ANTIMALARIAL ACTIVITY OF MEFLOQUINE AND QINGHAOSU

169Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Recent advances in malaria drug discovery

186Citations
N/AReaders
Get full text

The global pipeline of new medicines for the control and elimination of malaria

135Citations
N/AReaders
Get full text

Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria

67Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hombhanje, F. W., Linge, D., Saweri, A., Kuanch, C., Jones, R., Toraso, S., … Sapuri, M. (2009). Artemisinin-naphthoquine combination (ARCOTM) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy. Malaria Journal, 8(1). https://doi.org/10.1186/1475-2875-8-196

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

59%

Researcher 13

23%

Professor / Associate Prof. 6

11%

Lecturer / Post doc 4

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 32

58%

Agricultural and Biological Sciences 15

27%

Biochemistry, Genetics and Molecular Bi... 5

9%

Pharmacology, Toxicology and Pharmaceut... 3

5%

Save time finding and organizing research with Mendeley

Sign up for free